What is it about?

In this study, we contribute to the personalized medicine and health care management literature by developing and testing a new participative design approach. We propose that involving gastroenterologists in the development of a predictive test to assist them in their clinical decision-making process for the treatment of inflammatory bowel diseases will increase the likelihood of their acceptance of the innovation. Based on data obtained from 6 focus groups across Canada from a total of 28 physicians, analyses reveal that current tools do not enable discriminating between treatment options to find the best fit for each patient. Physicians expect a new predictive tool to have the capability of showing clear reliability and significant benefits for the patient, while being accessible in a timely manner that facilitates clinical decisions. Physicians also insist on their key role in the implementation process, hence confirming the relevance and importance of participative designs in personalized medicine.

Featured Image

Read the Original

This page is a summary of: Exploring the Use of a Participative Design in the Early Development of a Predictive Test: The Importance of Physician Involvement, Public Health Genomics, January 2017, Karger Publishers,
DOI: 10.1159/000479289.
You can read the full text:

Read

Contributors

The following have contributed to this page